Recalls, Market Withdrawals, & Safety Alerts
The list below provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this page. See Additional information about recalls for a more complete listing.
The Recalls, Market Withdrawals & Safety Alerts are available on FDA’s website for three years before being archived. To search archived content, visit Search FDA Archive and input the name of the product and/or company name in the Search terms box as well as the year to get the most inclusive search results. To scroll through archived Recalls, Market Withdrawals & Safety Alerts content by year, see the Recall and Safety Alerts Archive.
Sign up to receive Recalls, Market Withdrawals and Safety Alerts.* FDA Employees: Use Chrome to Subscribe until further notice.
| Date | Brand Name(s) | Product Description | Product Type | Recall Reason Description | Company Name | Terminated Recall | Excerpt |
|---|---|---|---|---|---|---|---|
| Mylan Institutional LLC | Octreotide Acetate Injection, 500 mcg/mL | Drugs | Due to glass particulates | Mylan Institutional LLC, a Viatris company | Terminated | … Mylan Institutional LLC … Mylan Institutional LLC, a Viatris company … FOR IMMEDIATE RELEASE – PITTSBURGH, October 25, 2022- Mylan Institutional LLC, a Viatris company, is voluntarily recalling lot AJ21002, exp … particulate matter, such as a glass, could lead to events including, but not limited to, local irritation or swelling, … | |
| Semglee | Insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens | Drugs | Missing Label | Mylan Pharmaceutical Inc. | Terminated | … Semglee … Mylan Pharmaceutical Inc. … PITTSBURGH – Jan. 18, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of its … Consumers with questions regarding this recall can contact Viatris Customer Relations by 800-796-9526 or … |